Lutetium Lu 177-Dotatate
This page contains brief information about lutetium Lu 177-dotatate and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.
Use in Cancer
Lutetium Lu 177-dotatate is approved to treat:
- Gastroenteropancreatic neuroendocrine tumors. It is used in adult patients whose cancer is somatostatin receptor positive.
Lutetium Lu 177-dotatate is also being studied in the treatment of other types of cancer.
More About Lutetium Lu 177-Dotatate
Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.
Research Results and Related Resources
Clinical Trials Accepting Patients
Find Clinical Trials for Lutetium Lu 177-dotatate - Check for trials from NCI's list of cancer clinical trials now accepting patients.